VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654

Sort by:

Fibromyalgia (Fibromyalgia Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Fibromyalgia (Fibromyalgia Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Fi...

February 2023 50 pages

Fibrosarcoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Fibrosarcoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Fibrosarcoma pipeline cand...

February 2023 110 pages

Fragile X Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Fragile X Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Fragile X Syndrome p...

February 2023 170 pages

Friedreich Ataxia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Friedreich Ataxia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Friedreich Ataxia pip...

February 2023 140 pages

Functional (Non Ulcer) Dyspepsia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Functional (Non Ulcer) Dyspepsia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Functi...

February 2023 40 pages

Gastric Ulcers Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Gastric Ulcers Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Gastric Ulcers pipeline...

February 2023 60 pages

Gastritis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Gastritis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Gastritis pipeline candidate,...

February 2023 70 pages

Gastroenteritis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Gastroenteritis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Gastroenteritis pipelin...

February 2023 60 pages

Gaucher Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Gaucher Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Gaucher Disease pipelin...

February 2023 170 pages

Genital Herpes Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Genital Herpes Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Genital Herpes pipeline...

February 2023 120 pages

Gingivitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Gingivitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Gingivitis pipeline candidat...

February 2023 40 pages

Gliosarcoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Gliosarcoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Gliosarcoma pipeline candid...

February 2023 150 pages

Globoid Cell Leukodystrophy (Krabbe Disease) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Globoid Cell Leukodystrophy (Krabbe Disease) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each o...

February 2023 50 pages

Gonorrhea Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Gonorrhea Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Gonorrhea pipeline candidate,...

February 2023 70 pages

Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development...

February 2023 40 pages

Gouty Arthritis (Gout) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Gouty Arthritis (Gout) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Gouty Arthritis...

February 2023 190 pages

Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2...

February 2023 60 pages

Grass Pollen Allergy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Grass Pollen Allergy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Grass Pollen Aller...

February 2023 50 pages

Graves Diseases Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Graves Diseases Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Graves Diseases pipelin...

February 2023 40 pages

Graves’ Ophthalmopathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Graves’ Ophthalmopathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Graves’ Ophthalm...

February 2023 80 pages

Guillain-Barre Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Guillain-Barre Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Guillain-Barre...

February 2023 60 pages

Haemophilus Influenzae Type B Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Haemophilus Influenzae Type B Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of th...

February 2023 90 pages

Hairy Cell Leukemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hairy Cell Leukemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hairy Cell Leukemia...

February 2023 80 pages

Hand, Foot and Mouth Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hand, Foot and Mouth Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hand, Foot...

February 2023 60 pages

Heart Transplant Rejection Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Heart Transplant Rejection Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Heart Transp...

February 2023 40 pages

Heavy Metal Poisoning Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Heavy Metal Poisoning Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Heavy Metal Poiso...

February 2023 40 pages

Hemophilia B (Factor IX Deficiency) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hemophilia B (Factor IX Deficiency) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hem...

February 2023 150 pages

Hepatic Encephalopathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hepatic Encephalopathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hepatic Encephal...

February 2023 60 pages

Hepatitis A Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hepatitis A Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hepatitis A pipeline candid...

February 2023 50 pages

Hepatitis D Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hepatitis D Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hepatitis D pipeline candid...

February 2023 80 pages

Herpes Labialis (Oral Herpes) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Herpes Labialis (Oral Herpes) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Herpes La...

February 2023 50 pages

Herpes Zoster (Shingles) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Herpes Zoster (Shingles) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Herpes Zoster...

February 2023 130 pages

Heterozygous familial hypercholesterolemia (heFH) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Heterozygous familial hypercholesterolemia (heFH) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For e...

February 2023 70 pages

Hidradenitis Suppurativa Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hidradenitis Suppurativa Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hidradenitis S...

February 2023 50 pages

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under developmen...

February 2023 40 pages

Hospital Acquired Pneumonia (HAP) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hospital Acquired Pneumonia (HAP) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hospi...

February 2023 190 pages

House Dust Mite Allergy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

House Dust Mite Allergy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the House Dust Mite...

February 2023 40 pages

Hyperalgesia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hyperalgesia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hyperalgesia pipeline cand...

February 2023 40 pages

Hypereosinophilic Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hypereosinophilic Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hypereosinop...

February 2023 40 pages

Hyperglycemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hyperglycemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hyperglycemia pipeline ca...

February 2023 90 pages

Hyperinsulinemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hyperinsulinemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hyperinsulinemia pipel...

February 2023 50 pages

Hyperphosphatemia In Chronic Kidney Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hyperphosphatemia In Chronic Kidney Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of...

February 2023 50 pages

Hypertrophic Cardiomyopathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hypertrophic Cardiomyopathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hypertrophi...

February 2023 100 pages

Hyperuricemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hyperuricemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hyperuricemia pipeline ca...

February 2023 120 pages

Hypoglycemia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hypoglycemia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hypoglycemia pipeline cand...

February 2023 70 pages

Hypoparathyroidism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hypoparathyroidism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hypoparathyroidism p...

February 2023 60 pages

Hypopharyngeal Cancer Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hypopharyngeal Cancer Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hypopharyngeal Ca...

February 2023 180 pages

Hypothyroidism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Hypothyroidism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Hypothyroidism pipeline...

February 2023 40 pages

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1&nb...

February 2023 180 pages

Impetigo Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Impetigo Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1 2023. For each of the Impetigo pipeline candidate, d...

February 2023 40 pages

Filters

Clear all

Publishers

VPAResearch

55,654

Price

—

Date

—

Pages

—

Offers